Recombinant bacillus Calmette-Guerin in urothelial bladder cancer immunotherapy: current strategies

被引：8

作者：

Wang, Yonghua ^{[1
]}

Yang, Meng ^{[1
]}

Yu, Qinchao ^{[1
]}

Yu, Lun ^{[1
]}

Shao, Shixiu ^{[1
]}

Wang, Xinsheng ^{[1
]}

机构：

[1] Qingdao Univ, Affiliated Hosp, Dept Urol, Qingdao 266071, Peoples R China

来源：

EXPERT REVIEW OF ANTICANCER THERAPY | 2015年 / 15卷 / 01期

基金：

中国国家自然科学基金;

关键词：

bacillus Calmette-Guerin; BCG; immunotherapy; intravesical therapy; recombinant BCG; urothelial bladder cancer; TRANSITIONAL-CELL CARCINOMA; EXPRESSING PERTUSSIS TOXIN; GAMMA-INDUCING FACTOR; MYCOBACTERIUM-BOVIS; IFN-GAMMA; INTRAVESICAL THERAPY; DNA VACCINES; MITOMYCIN-C; TH1-STIMULATING CYTOKINES; PLUS INTERFERON-ALPHA-2B;

D O I：

10.1586/14737140.2015.961430

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Bacillus Calmette-Guerin (BCG) has been used in the intravesical treatment of urothelial bladder cancer (UBC) for three decades. Despite its efficacy, intravesical BCG therapy is associated with some limitations such as side effects and BCG failure, which have inspired multiple ways to improve it. Recent advances have focused on recombinant BCG (rBCG) which provides a novel tactic for modification of BCG. To date, a number of rBCG strains have been developed and demonstrated to encourage efficacy and safety in preclinical and clinical studies. This review summarizes current rBCG strategies, concerns and future directions in UBC immunotherapy with an intention to encourage further research and eventually to inform clinical decisions.

引用

页码：85 / 93

页数：9

共 50 条

[31] Optimal Dose and Duration of bacillus Calmette-Guerin Therapy for Urothelial Carcinoma of the Bladder
Homma, Yukio
Nakagawa, Tohru
JOURNAL OF UROLOGY, 2016, 195 (01) : 9 - 10
[32] Prevention of Bacillus Calmette-Guerin immunotherapy complications
Colombet, Marc
Picard, Aude
PROGRES EN UROLOGIE, 2008, 18 : S105 - S110
[33] The Role of Bacillus Calmette-Guerin in the Treatment of Non-Muscle-Invasive Bladder Cancer
Gontero, Paolo
Bohle, Andreas
Malmstrom, Per-Uno
O'Donnell, Michael A.
Oderda, Marco
Sylvester, Richard
Witjes, Fred
EUROPEAN UROLOGY, 2010, 57 (03) : 410 - 429
[34] Combined Thermo-Chemotherapy for Recurrent Bladder Cancer After Bacillus Calmette-Guerin
Nativ, Ofer
Witjes, J. Alfred
Hendricksen, Kees
Cohen, Michael
Kedar, Daniel
Sidi, Ami
Colombo, Renzo
Leibovitch, Ilan
JOURNAL OF UROLOGY, 2009, 182 (04) : 1313 - 1317
[35] Treatment Options Available for Bacillus Calmette-Guerin Failure in Non-muscle-invasive Bladder Cancer
Yates, David R.
Brausi, Maurizio A.
Catto, James W. F.
Dalbagni, Guido
Roupret, Morgan
Shariat, Shahrokh F.
Sylvester, Richard J.
Witjes, J. Alfred
Zlotta, Alexandre R.
Palou-Redorta, Juan
EUROPEAN UROLOGY, 2012, 62 (06) : 1088 - 1096
[36] Antitumor Efficacy of Bacillus Calmette-Guerin Loaded Cationic Nanoparticles for Intravesical Immunotherapy of Bladder Tumor Induced Rat Model
Erdogar, Nazli
Iskit, Alper B.
Eroglu, Hakan
Sargon, Mustafa F.
Mungan, N. Aydin
Bilensoy, Erem
JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY, 2015, 15 (12) : 10156 - 10164
[37] Safety profiles of intravesical Bacillus Calmette-Guerin in bladder cancer
Peng, Yun
Song, Yuxuan
Qin, Caipeng
Du, Yiqing
Xu, Tao
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2024, 20 (01)
[38] Bacillus Calmette-Guerin Osteomyelitis Mimicking Spinal Metastasis from Urothelial Cell Carcinoma of the Bladder
Patel, Amit R.
Sabanegh, Edmund S.
Jones, J. Stephen
Gordon, Steven M.
Ballin, Mitchell
Ruggieri, Paul M.
Stephenson, Andrew J.
EUROPEAN UROLOGY, 2010, 58 (06) : 934 - 937
[39] Immunotherapy for orthotopic murine bladder cancer using bacillus Calmette-Guerin recombinant protein Mpt-64
Yu, Dah-Shyong
Lee, Chi-Feng
Chang, Sun-Yran
JOURNAL OF UROLOGY, 2007, 177 (02) : 738 - 742
[40] Bacillus Calmette-Guerin in the management of superficial bladder cancer
Kapoor, Rakesh
Vijjan, Vivek
Singh, Pratipal
INDIAN JOURNAL OF UROLOGY, 2008, 24 (01) : 72 - 76

← 1 2 3 4 5 →